Article ; Online: Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort.
Rheumatology (Oxford, England)
2021 Volume 60, Issue 10, Page(s) 4737–4747
Abstract: Objectives: Vitamin D (25(OH)D) deficiency and metabolic syndrome (MetS) may both contribute ... phenotype, therapy and vitamin D levels with MetS and insulin resistance.: Methods: The Systemic Lupus ... centres across 11 countries from 2000. Clinical, laboratory and therapeutic data were collected. Vitamin D ...
Abstract | Objectives: Vitamin D (25(OH)D) deficiency and metabolic syndrome (MetS) may both contribute to increased cardiovascular risk in SLE. We aimed to examine the association of demographic factors, SLE phenotype, therapy and vitamin D levels with MetS and insulin resistance. Methods: The Systemic Lupus International Collaborating Clinics (SLICC) enrolled patients recently diagnosed with SLE (<15 months) from 33 centres across 11 countries from 2000. Clinical, laboratory and therapeutic data were collected. Vitamin D level was defined according to tertiles based on distribution across this cohort, which were set at T1 (10-36 nmol/l), T2 (37-60 nmol/l) and T3 (61-174 nmol/l). MetS was defined according to the 2009 consensus statement from the International Diabetes Federation. Insulin resistance was determined using the HOMA-IR model. Linear and logistic regressions were used to assess the association of variables with vitamin D levels. Results: Of the 1847 patients, 1163 (63%) had vitamin D measured and 398 (34.2%) subjects were in the lowest 25(OH)D tertile. MetS was present in 286 of 860 (33%) patients whose status could be determined. Patients with lower 25(OH)D were more likely to have MetS and higher HOMA-IR. The MetS components, hypertension, hypertriglyceridemia and decreased high-density lipoprotein (HDL) were all significantly associated with lower 25(OH)D. Increased average glucocorticoid exposure was associated with higher insulin resistance. Conclusions: MetS and insulin resistance are associated with lower vitamin D in patients with SLE. Further studies could determine whether vitamin D repletion confers better control of these cardiovascular risk factors and improve long-term outcomes in SLE. |
---|---|
MeSH term(s) | Adult ; Cohort Studies ; Cross-Sectional Studies ; Female ; Global Health/statistics & numerical data ; Humans ; Insulin Resistance ; Lupus Erythematosus, Systemic/blood ; Lupus Erythematosus, Systemic/complications ; Male ; Metabolic Syndrome/epidemiology ; Metabolic Syndrome/etiology ; Vitamin D/analogs & derivatives ; Vitamin D/blood ; Vitamin D Deficiency/blood ; Vitamin D Deficiency/complications ; Vitamin D Deficiency/epidemiology ; Young Adult |
Chemical Substances | Vitamin D (1406-16-2) ; 25-hydroxyvitamin D (A288AR3C9H) |
Language | English |
Publishing date | 2021-04-05 |
Publishing country | England |
Document type | Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't |
ZDB-ID | 1464822-2 |
ISSN | 1462-0332 ; 1462-0324 |
ISSN (online) | 1462-0332 |
ISSN | 1462-0324 |
DOI | 10.1093/rheumatology/keab090 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 240: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 497: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.